Company profile for NRx Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NRx believes in a world where scientific advancement makes untreatable diseases treatable. We apply our unique clinical and scientific expertise, partnered with leading medical experts, to develop known molecules for medical conditions with no indicated therapies. We are committed to bringing new medicines and hope for people with chronic medical conditions so they may live healthier and more fulfilling lives. The company is b...
NRx believes in a world where scientific advancement makes untreatable diseases treatable. We apply our unique clinical and scientific expertise, partnered with leading medical experts, to develop known molecules for medical conditions with no indicated therapies. We are committed to bringing new medicines and hope for people with chronic medical conditions so they may live healthier and more fulfilling lives. The company is built upon 30 years of basic science and clinical expertise in understanding the role of the brain’s N-methyl-D-aspartate (NMDA) receptor in regulating human thought processes in general and in regulating depression

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Wilmington, Delaware
Telephone
Telephone
+1 484.254.6134
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/02/3197945/0/en/NRx-Pharmaceuticals-Announces-US-Food-and-Drug-Administration-FDA-Receipt-of-ANDA-for-KETAFREE-a-Preservative-Free-IV-Ketamine.html

GLOBENEWSWIRE
02 Dec 2025

https://www.globenewswire.com/news-release/2025/12/01/3196980/0/en/NRx-Pharmaceuticals-NASDAQ-NRXP-and-HOPE-Therapeutics-to-Present-at-NobleCon21-Noble-Capital-Markets-Twenty-First-Annual-Emerging-Growth-Equity-Conference.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/17/3189115/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/11/12/3186285/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-to-Report-Third-Quarter-2025-Financial-Results-on-November-17-2025.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184538/0/en/HOPE-Therapeutics-Inc-an-NRx-Pharmaceuticals-Subsidiary-Announces-First-in-Florida-Initiation-of-One-Day-ONE-D-Depression-Treatment-in-Partnership-with-Ampa-Health.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/10/20/3169337/0/en/HOPE-Therapeutics-Inc-and-NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Announce-Inclusion-of-Cohen-Associates-LLC-of-Sarasota-FL-into-the-HOPE-Network-and-Appointment-of-Dr-Rebecca-Cohen-as.html

GLOBENEWSWIRE
20 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty